HomeQuestion

Can procalcitonin be used as a marker for endothelial dysfunction emanating from chronic inflammation of obesity?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Do you tend to avoid the use of oral weight loss stimulant medications such as phentermine in obese patients on SSRI or ADHD treatments?

Can fatty liver disease present with elevations in alkaline phosphatase without other liver enzyme elevations (AST and ALT)?

When treating fatty liver disease with resmetirom, how often should a FibroScan be repeated to assess treatment response?

Are you more likely to recommend medical management for obesity instead of bariatric surgery in patients with preexisting hypothyroidism, given a recent study showing increased risks of complications?

How long do you typically treat patients with phentermine for weight loss and what clinical markers do you follow?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.